Xu, T. et al. Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature 548, 228–233 (2017).
Holt, M. C. et al. Biochemical characterization and structure-based mutational analysis provide insight into the binding and mechanism of action of novel aspartate aminotransferase inhibitors. Biochemistry 57, 6604–6614 (2018).
Birsoy, K. et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162, 540–551 (2015).
Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808–812 (2010).
Yang, L. et al. Metabolomic and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle. I. Interrelation between gluconeogenesis and cataplerosis; formation of methoxamates from aminooxyacetate and ketoacids. J. Biol. Chem. 283, 21978–21987 (2008).
Parker, S. J. et al. Spontaneous hydrolysis and spurious metabolic properties of α-ketoglutarate esters. Nat. Commun. 12, 4905 (2021).
Kumar, P., Natarajan, K. & Shanmugam, N. High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression. Cell. Signal. 26, 528–539 (2014).
Zhang, J., Jin, H., Xu, Y. & Shan, J. Rapamycin modulate Treg/Th17 balance via regulating metabolic pathways: a study in mice. Transplant Proc. 51, 2136–2140 (2019).
Shi, L. Z. et al. HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367–1376 (2011).
Gerriets, V. A. et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 125, 194–207 (2015).
Shin, B. et al. Mitochondrial oxidative phosphorylation regulates the fate decision between pathogenic Th17 and regulatory T cells. Cell Rep. 30, 1898–1909 (2020).
Berod, L. et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20, 1327–1333 (2014).
Stoop, J. N., Tibbitt, C. A., van Eden, W., Robinson, J. H. & Hilkens, C. M. The choice of adjuvant determines the cytokine profile of T cells in proteoglycan-induced arthritis but does not influence disease severity. Immunology 138, 68–75 (2013).
More News
Retractions are part of science, but misconduct isn’t — lessons from a superconductivity lab
Valleytronics in bulk MoS2 with a topologic optical field – Nature
Are robots the solution to the crisis in older-person care?